Table 4.

Prevalences of complications during hospitalization of COVID-19 patients in the ARDS and non-ARDS groups

Complication	Total (n = 94)	ARDS (n = 64)	Non-ARDS (n = 30)	P valuea
Septic shock	51 (54.25%)	46 (71.87%)	5 (16.67%)	< 0.001
DIC	32 (34.04%)	28 (43.75%)	4 (13.33%)	0.008
AKI	36 (38.29%)	34 (53.12%)	2 (6.67%)	< 0.001
Cardiac injury	53 (56.38%)	50 (78.12%)	3 (10%)	< 0.001
Hepatic injuryy	21 (22.34%)	18 (28.13%)	3 (10%)	0.089
28-day survival	43 (45.74%)	18 (28.13%)	25 (83.33%)	< 0.001

^aThe comparison of the ARDS and non-ARDS groups

DIC disseminated intravascular coagulation, AKI acute kidney injury